[Comparative pharmacokinetic study of sodium Danshensu and Salvia miltiorrhiza injection in rat]
- PMID: 20209966
[Comparative pharmacokinetic study of sodium Danshensu and Salvia miltiorrhiza injection in rat]
Abstract
Objective: To develop a HPLC method for determination of the concentration of Danshensu in rat plasma and undertake comparative pharmacokinetic study of sodium danshensu and Salvia miltiorrhiza injection in rat as well as to assess the effect of other components of Salvia miltiorrhiza injection on the pharmacokinetics of Danshensu.
Method: Rats received an iv. infusion of sodium Danshensu or S. miltiorrhiza injection (equal to Danshensu 30 mg x kg(-1)). Blood samples were collected from carotid artery. Plasma concentration of Danshensu extracted with perchloric acid was measured. The pharmacokinetic parameters were calculated with DAS2.0 software.
Result: A good linear relationship of Danshensu was obtained from the range of 0.5 to 80.0 mg x L(-1), and the lowest limit of determination was 0.2 mg x L(-1). The plasma concentration time curves of Danshensu were best fitted with two-compartment models for Danshensu itself and for Salvia miltiorrhiza injection as well. The pharmacokinetic parameters such as t1/2alpha, AUC, CL had significant differences.
Conclusion: The concomitant components in Salvia miltiorrhiza injection influence the pharmacokinetic properties of Danshensu and speed up its disposition and elimination.
Similar articles
-
[Tissue distribution in mice of danshensu from sodium danshensu and Salvia miltiorrhiza injection].Zhongguo Zhong Yao Za Zhi. 2011 Jun;36(11):1516-8. Zhongguo Zhong Yao Za Zhi. 2011. PMID: 22779190 Chinese.
-
[Drug dynamics research of salvia miltiorrhiza in rabbit plasma and aqueous humor after intravenous injection].Zhonghua Yan Ke Za Zhi. 2013 Sep;49(9):835-40. Zhonghua Yan Ke Za Zhi. 2013. PMID: 24330935 Chinese.
-
[Determination of danshensu in rat serum after oral administer compound Salvia recipe].Zhongguo Zhong Yao Za Zhi. 2003 Jun;28(6):562-5. Zhongguo Zhong Yao Za Zhi. 2003. PMID: 15015342 Chinese.
-
Efficacy and safety of Salvia miltiorrhiza (Salvia miltiorrhiza Bunge) and ligustrazine injection in the adjuvant treatment of early-stage diabetic kidney disease: A systematic review and meta-analysis.J Ethnopharmacol. 2021 Dec 5;281:114346. doi: 10.1016/j.jep.2021.114346. Epub 2021 Jun 18. J Ethnopharmacol. 2021. PMID: 34153447
-
Salvia miltiorrhiza: A source for anti-Alzheimer's disease drugs.Pharm Biol. 2016;54(1):18-24. doi: 10.3109/13880209.2015.1027408. Epub 2015 Apr 10. Pharm Biol. 2016. PMID: 25857808 Review.
Cited by
-
Enhanced Neurogenesis and Collaterogenesis by Sodium Danshensu Treatment After Focal Cerebral Ischemia in Mice.Cell Transplant. 2018 Apr;27(4):622-636. doi: 10.1177/0963689718771889. Cell Transplant. 2018. PMID: 29984620 Free PMC article.
-
Sodium Danshensu protects against oxygen glucose deprivation/reoxygenation-induced astrocytes injury through regulating NOD-like receptor pyrin domain containing 3 (NLRP3) inflammasome and tuberous sclerosis complex-2 (TSC2)/mammalian target of rapamycin (mTOR) pathways.Ann Transl Med. 2022 Oct;10(20):1097. doi: 10.21037/atm-22-2143. Ann Transl Med. 2022. PMID: 36388798 Free PMC article.